PROVIDER PROFILE · NPI 1982661849

David Kaplan

DermatologyOverland Park, KSI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,349

Beneficiaries

—

Total drug cost

$651K

Distinct drugs

Brand share

14.9%

Top prescribed drugs

Finasteride173 claims

Ketoconazole86 claims

Imiquimod82 claims

Doxycycline Hyclate68 claims

Amitriptyline Hcl60 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$26K

Payment records

311

By payment type

Consulting Fee$19K

Food and Beverage$6K

Travel and Lodging$1K

Education$100

REFERRAL NETWORK

Where David Kaplan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Mawd Pathology Group Pa Clinical Laboratory · Lenexa, KS	148	208
ST LUKES HOSPITAL OF KANSAS CITY	49	86
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	41	56
MIDWEST DIVISION - MMC, LLC	36	76
SHAWNEE MISSION MEDICAL CENTER INC	30	40
MID AMERICA PATHOLOGY LABORATORY LLC	29	45
SAINT LUKES SOUTH HOSPITAL, INC.	22	27
ST. JOSEPH MEDICAL CENTER	20	26
LABORATORY CORPORATION OF AMERICA HOLDINGS	19	22
OLATHE MEDICAL CENTER INC	13	16
David Bock Urology · Overland Park, KS	11	32
LABORATORY CORPORATION OF AMERICA HOLDINGS	11	12

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history